Raycaster
AI NativeAI-native document workspace for life sciences
Est 2024|Raised $500K
Published Aug 14, 2026
Raycaster participated in a well-known accelerator program in late 2024 and appears to be operating via pilot deployments rather than broad self-serve adoption based on the public information reviewed.
| Starting Price | Not publicly listed (demo / sales engagement) | Quote-based / enterprise | Quote-based |
| Typical Use Case | AI-assisted cross-document drafting and impact analysis for regulated life-sciences documents | Enterprise platform for regulated content, workflows, audit trails, and life-sciences operations | QMS/MES platform focused on quality and manufacturing compliance |
| Key Strengths | Document-centric drafting across interdependent files, impact analysis, and in-platform citations | Mature regulatory platform ecosystem; extensive validation and audit tooling; broad adoption | Deep quality and manufacturing compliance workflows; life-sciences focus |
| Key Weaknesses | Early-stage: limited public proof points; integration depth and certification scope not publicly documented | Implementation complexity and cost | Cost and implementation overhead; focus on QMS/MES rather than authoring-first scenarios |
—